Article Details

Day One Biopharma Gets European Regulators' Orphan Designation for Glioma Treatment

Retrieved on: 2021-06-21 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Day One Biopharma Gets European Regulators' Orphan Designation for Glioma Treatment. View article details on hiswai:

Excerpt

By Kimberly Chin. Day One Biopharmaceuticals Inc. said it has received an orphan designation for its glioma treatment from European regulators, ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up